This grand round has already taken place.
A discussion on combination of high dose radiotherapy and immunotherapy in the treatment of glioblastoma
Dates and Times
Start: 2/14/2020 8:00 AM
End: 2/14/2020 9:00 AM
- Review current evidence behind combining radiotherapy and immunotherapy for treatment of GBM
- Present pre-clinical data for novel treatment paradigm
- Examine potential implications for normal brain tissue toxicity of the combined therapy
- Present prospective clinical trial to be launched at SBUH
HSC level 3, lecture hall 6
Stony Brook Medicine
Stony Brook, NY 11794
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.